POLARIS INDUSTRIES INVESTOR ALERT: Hagens Berman is

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
POLARIS INDUSTRIES INVESTOR ALERT: Hagens Berman is Investigating Possible Securities Law Violations by Polaris Industries Inc. and Certain Officers

SAN FRANCISCO, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Polaris Industries Inc. that the firm is investigating possible securities law violations by the Company and its officers.

To all investors in PII:  If you purchased or otherwise acquired securities of PII between July 19, 2016 and September 11, 2016 and suffered over $50,000 in losses contact Hagens Berman Sobol Shapiro LLP.  For more information visit:

https://www.hbsslaw.com/cases/PII

or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing PII@hbsslaw.com .

On July 20, 2016, Polaris reported its 2016 second quarter results and provided fiscal year 2016 earnings guidance of $6 - $6.30 per share.  In response, Polaris stock price rose approximately 9% to close at $95.03.

Then, on July 25, 2016 the Company voluntarily issued stop-ride/stop-sale advisory for its MY2016 RZR Turbo Off-Road Vehicles “due to a potential fire hazard.”

On September 12, 2016, Polaris slashed its fiscal year 2016 earnings guidance to $3.30 - $3.80 per share and explained:  “the Company has experienced additional RZR thermal-related issues and was unable to sufficiently validate the initially identified RZR Turbo recall repair, necessitating a more complex and expensive repair solution [and] [a]s a result, the voluntary stop ride/stop sale notification issued on July 25, 2016 remained in place significantly longer than originally anticipated.”  In response, Polaris stock price fell approximately 5% to close at $76.79.

SEC filings show that during August 2016 Polaris’ Chief Financial Officer and its President of the Off-Road Vehicles business together sold shares for total proceeds of over $623,000.

“We’re looking into when the Company and its senior officers knew the advisory should be extended relative to the dramatic 45% reduction in the low-end guidance and of course the propriety of insider sales,” said Hagens Berman partner Reed Kathrein.

Whistleblowers: Persons with non-public information regarding Polaris Industries should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email.  PII@hbsslaw.com .

About Hagens Berman Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com . Read the Firm’s Securities Newsletter , and visit the blog . For the latest news visit our newsroom or follow us on Twitter at @classactionlaw .

Contact: Reed Kathrein, 510-725-3000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Classic vs. Youngtimer Cars: Evolution in Collecting

Updated Category News Views 90

The Collector's Journey: Classic Cars vs. Youngtimers Ever notice how car collecting has its own circles of fame? You're either basking in the glow of a vintage classic or eyeing a youngtimer that’s just catching steam. In this article from HelloNation, Engels Gualdani — the classic car sage of Hilton, NY — helps untangle these categories for us, and it’s a lesson...

Continue Reading
Smart Banner Choices: Decisions Beyond Design

Updated Category News Views 152

Location, Location, Location: Banner Insights Picking a banner isn't just a quick snap decision. You got to think big, and location is a starting line. Adam Norsworthy from Minuteman Press underscores that understanding how and where this piece of publicity will hang matters more than you might guess. Outdoor or indoor isn't just a weather question; it's a matter of...

Continue Reading
PangeAI and Sky Blue Transform Data Center Decisions

Updated Category News Views 80

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 37

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Toys"R"Us Rolls Out 160 U.S. Stores, NYC Celebration

Updated Category News Views 146

Rebuilding the Toy Empire After a rough few years, Toys"R"Us is clawing its way back into the hearts—and wallets—of American shoppers. With 160+ new standalone stores popping up like mushrooms after rain, these guys aren't just playing games. This is a strategic move to reestablish their presence in the retail landscape just before the holiday shopping frenzy kicks...

Continue Reading
Nagarro's Earnings Show Stagnant Growth Amid Flat Margins

Updated Category News Views 96

Nagarro's Financial Picture: A Glimpse Live a day in the trading pits and you'll learn to spot when a company is merely treading water. That's the vibe I'm getting from Nagarro's Q3 2026 results. They might label themselves as an AI-native leviathan, but these numbers spell out a story of struggle wrapped in fancy buzzwords. Revenue Uptick or Revenue Hiccup? For the nine...

Continue Reading
APEC Summit 2026: Shenzhen in the Spotlight

Updated Category News Views 58

An International Stage for Shenzhen Alright, folks, here's the deal. We’ve got the 2026 APEC Summit rolling into Shenzhen, perched right there in Guangdong Province, and the world’s eyes are glued to it. Happens November 18–19, and you better believe it’s a magnet for all things global. The China Media Group’s Chinese Global Program Center isn’t missing a...

Continue Reading
Endava Faces Class Action: Investor Reactions and Next Steps

Updated Category News Views 72

Trouble at Endava: Leadership Shakeup and Financial Concerns So, here's the kicker—Endava's got itself into one mighty mess worth chewing over with your morning coffee. When your top brass drops like flies, and you're fumbling your financials, investors start sweating bullets. On October 28, 2026, Endava plc (NYSE: DAVA) confesses to some serious accounting missteps....

Continue Reading
First Horizon's $25M Bet: New Center Transforms Houston

Updated Category News Views 76

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 58

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading

Top 5 Most Recently Viewed Articles

Strengthening Heart and Kidney Health Through Collaboration

Updated Category News Views 264

Collaboration for Health Awareness In an exciting development, the American Kidney Fund (AKF) has forged a partnership with the American Heart Association (AHA) as part of their Cardiovascular-Kidney-Metabolic Health Initiative™. This collaboration aims to raise awareness regarding the crucial link between kidney disease and cardiovascular conditions, both of which...

Continue Reading
Kering Faces Challenges Amid Analyst Downgrades and Market Slowdown

Updated Category News Views 106

Kering Faces Challenges Amid Analyst Downgrades and Market Slowdown Kering (EPA: PRTP) has recently experienced a shift in market sentiment as analysts express increasing caution regarding its performance. TD Cowen has notably lowered its price target for Kering to €230 from €260, while sustaining a Hold rating for the stock. The adjustment signals growing concerns...

Continue Reading
Xi Jinping Champions Common Development at G20 Summit

Updated Category News Views 308

Xi Jinping's Vision for Global Cooperation at the G20 Summit Chinese President Xi Jinping recently made headlines during a significant gathering known as the G20 Summit. His participation underscored a strong commitment to fostering global cooperation and development, marking a notable moment in international relations. Advocating for a Unified Approach During his...

Continue Reading
OHA Secures Financing for Onex's Acquisition of Farsound

Updated Category News Views 84

OHA Leads Innovative Financing for Strategic Acquisition In a significant development in the financial world, Oak Hill Advisors (OHA) has taken on the role of Lead Left Arranger for a private unitranche financing aimed at supporting the acquisition of Farsound Aviation Limited by Onex. Farsound stands out in the aerospace engine maintenance, repair, and overhaul (MRO)...

Continue Reading
Zentalis Pharmaceuticals Rebounds After FDA Clearance for Azenosertib

Updated Category News Views 75

Zentalis Pharmaceuticals Advances with Azenosertib Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL), located in San Diego, has some exciting updates for its stakeholders. The U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on the company's studies involving azenosertib. This is fantastic news, as it enables Zentalis to restart patient enrollment...

Continue Reading